Cargando…

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

Detalles Bibliográficos
Autores principales: Teles, Mayan S, Connolly, Caoilfhionn M, Wallwork, Rachel, Frey, Sarah, Chiang, Teresa Po-Yu, Alejo, Jennifer L, Albayda, Jemima, Christopher-Stine, Lisa, Segev, Dorry L, Werbel, William A, Paik, Julie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384401/
https://www.ncbi.nlm.nih.gov/pubmed/35758603
http://dx.doi.org/10.1093/rheumatology/keac370
_version_ 1784769435843690496
author Teles, Mayan S
Connolly, Caoilfhionn M
Wallwork, Rachel
Frey, Sarah
Chiang, Teresa Po-Yu
Alejo, Jennifer L
Albayda, Jemima
Christopher-Stine, Lisa
Segev, Dorry L
Werbel, William A
Paik, Julie J
author_facet Teles, Mayan S
Connolly, Caoilfhionn M
Wallwork, Rachel
Frey, Sarah
Chiang, Teresa Po-Yu
Alejo, Jennifer L
Albayda, Jemima
Christopher-Stine, Lisa
Segev, Dorry L
Werbel, William A
Paik, Julie J
author_sort Teles, Mayan S
collection PubMed
description
format Online
Article
Text
id pubmed-9384401
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93844012022-08-18 Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series Teles, Mayan S Connolly, Caoilfhionn M Wallwork, Rachel Frey, Sarah Chiang, Teresa Po-Yu Alejo, Jennifer L Albayda, Jemima Christopher-Stine, Lisa Segev, Dorry L Werbel, William A Paik, Julie J Rheumatology (Oxford) Published Online Only Oxford University Press 2022-06-27 /pmc/articles/PMC9384401/ /pubmed/35758603 http://dx.doi.org/10.1093/rheumatology/keac370 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
spellingShingle Published Online Only
Teles, Mayan S
Connolly, Caoilfhionn M
Wallwork, Rachel
Frey, Sarah
Chiang, Teresa Po-Yu
Alejo, Jennifer L
Albayda, Jemima
Christopher-Stine, Lisa
Segev, Dorry L
Werbel, William A
Paik, Julie J
Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title_full Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title_fullStr Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title_full_unstemmed Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title_short Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
title_sort safety and immunogenicity of fifth dose sars-cov-2 vaccination in patients with autoimmune disease: a case series
topic Published Online Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384401/
https://www.ncbi.nlm.nih.gov/pubmed/35758603
http://dx.doi.org/10.1093/rheumatology/keac370
work_keys_str_mv AT telesmayans safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT connollycaoilfhionnm safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT wallworkrachel safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT freysarah safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT chiangteresapoyu safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT alejojenniferl safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT albaydajemima safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT christopherstinelisa safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT segevdorryl safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT werbelwilliama safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries
AT paikjuliej safetyandimmunogenicityoffifthdosesarscov2vaccinationinpatientswithautoimmunediseaseacaseseries